Cargando…
The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome
BACKGROUND: Vestibular syndrome is often accompanied by nausea. Drugs currently approved for its treatment have been developed to stop vomiting but not nausea. The efficacy of 5-HT(3) receptor antagonists to reduce nausea has been described for chemotherapy, but not for nausea secondary to vestibula...
Autores principales: | Foth, S., Meller, S., Kenward, H., Elliott, J., Pelligand, L., Volk, H. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218477/ https://www.ncbi.nlm.nih.gov/pubmed/34154584 http://dx.doi.org/10.1186/s12917-021-02931-9 |
Ejemplares similares
-
Ondansetron in dogs with nausea associated with vestibular disease: A double‐blinded, randomized placebo‐controlled crossover study
por: Henze, Lea, et al.
Publicado: (2022) -
Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study
por: Kenward, Hannah, et al.
Publicado: (2017) -
Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration
por: Kenward, Hannah, et al.
Publicado: (2014) -
Pharmacokinetics and anti‐nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea
por: Sotelo, Cindy K., et al.
Publicado: (2022) -
Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting
por: Matsota, Paraskevi, et al.
Publicado: (2015)